Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening

NCT03611881 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03611881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2019
Completion date
January 31, 2024
Enrollment
642 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

smoking, tobacco